撰文 | 唐东豪   责编 | 周叶斌在儿童肿瘤中，原发性肝癌（PLC）相对罕见，仅占所有儿童癌症的0.5%至1.5%。主要包括肝母细胞瘤（HB）和肝细胞癌（HCC）。而一种名为复合型肝细胞胆管癌（Combined ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Hepatocellular cancer, the most common form of primary liver cancer, is the fastest rising cause of cancer-related deaths in the United States. Texas has the highest incidence rates of HCC in the ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...